On February 6, 2024, the company announced an increase in its equity buyback plan. The company increased its authorization by $50 million, thereby bringing total authorization to $100 million.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.69 CNY | +1.28% |
|
-4.61% | -30.26% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-30.26% | 259M | |
+15.86% | 77.46B | |
+13.86% | 8.94B | |
-24.30% | 4.28B | |
+12.79% | 4.18B | |
+31.45% | 4.11B | |
+9.79% | 2.23B | |
-30.57% | 2.06B | |
+8.99% | 1.97B | |
-45.76% | 1.69B |
- Stock Market
- Equities
- 002873 Stock
- News Guiyang Xintian Pharmaceutical Co.,Ltd.
- Guiyang Xintian Pharmaceutical Co.,Ltd. announces an Increase in Equity Buyback.